Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;15(4):483-91.
doi: 10.1007/s10238-014-0321-6. Epub 2014 Dec 11.

Association between HBV Pre-S mutations and the intracellular HBV DNAs in HBsAg-positive hepatocellular carcinoma in China

Affiliations

Association between HBV Pre-S mutations and the intracellular HBV DNAs in HBsAg-positive hepatocellular carcinoma in China

Hui Wang et al. Clin Exp Med. 2015 Nov.

Abstract

This study aimed to investigate the association between HBV mutations and intrahepatic HBV status and to determine the clinical features and the contribution of HBV mutations to postoperative prognosis for hepatocellular carcinoma (HCC) patients with HBsAg (+) in China. Using TaqMan fluorescent real-time PCR, HBV covalently closed circular DNA (cccDNA) and total DNA (tDNA) were both quantified in 106 pairs of tumor tissues (TT) and adjacent non-tumor tissues (ANTT) obtained from HCC patients who received no antiviral treatment before surgical treatment. The prevalence of 19 hot spot mutations was evaluated by Sanger sequencing. HBV cccDNA and tDNA were lower in TT than in ANTT. The loads of cccDNA and tDNA in ANTT were associated with serum HBV DNA and HBeAg. Three Pre-S mutants (A2962G and C2964A in Pre-S1 and C105T in Pre-S2) were associated with higher tumor cccDNA levels (P < 0.05), and A2962G/C2964A mutants were associated with higher AFP levels. This would assist to disclose the virological features, to implement a more clinically personalized therapy and to improve the prognosis of HBV-related HCC patients.

Keywords: Covalently closed circular DNA; HCC; Hepatitis B virus; Pre-S; Variation.

PubMed Disclaimer

References

    1. Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2623-30 - PubMed
    1. Lancet. 2012 Mar 31;379(9822):1245-55 - PubMed
    1. Hepatology. 2011 Sep 2;54(3):829-36 - PubMed
    1. J Med Virol. 2013 Jun;85(6):987-95 - PubMed
    1. Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2362-8 - PubMed

Publication types

LinkOut - more resources